While considerable evidence indicates that exposure to the pollutant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) impairs T cell function, the precise mechanism underlying this effect is not well understood. Furthermore, relatively little is known about the effects of TCDD on the fate of activated, antigen-specific T cells in vivo. In the present study, we took advantage of major histocompatibility complex (MHC) class I-restricted tetramers and clonotypic anti-T cell receptor (TCR) antibodies to follow the fate of influenza virus-specific CD8 ؉ T cells in mice treated with TCDD.
Studies conducted over the past 25 years have clearly established that the immune system is one of the most sensitive targets for the pollutant 2, 3, 7, . Produced through a variety of manufacturing and incineration processes, TCDD and structurally related chemicals are widely distributed and persistent environmental contaminants that elicit their toxic and biological effects by binding to a ligand-activated transcription factor, the aryl hydrocarbon receptor (AhR). Studies with AhR-null mice indicate that most, if not all, of the immunotoxic effects of TCDD are mediated through an AhR-dependent pathway . Despite these findings, the precise mechanisms by which TCDD impairs the immune system are not known, nor have the immune cells directly targeted by TCDD been identified.
Although the mechanisms of TCDD immunotoxicity are not well understood, one adverse effect of TCDD that is consistently reported under a variety of exposure paradigms is suppression of T cell-mediated immune responses. In vivo exposure to TCDD impairs T cell functions such as proliferation, differentiation, cytokine production, and antibody responses to T-dependent antigens (reviewed in Kerkvliet, 2002) . Suppression of the cytotoxic T lymphocyte (CTL) response has also been reported in mice exposed to TCDD (Clark et al., 1983; Kerkvliet et al., 1996; Warren et al., 2000) . For example, using a P815 tumor allograft model, Kerkvliet et al. (1996) showed that exposure to TCDD dose-responsively suppressed splenic cytolytic activity, decreased the production of interleukin-2 (IL-2) and interferon-gamma (IFN␥) by CD8 ϩ T cells, and reduced the number of splenocytes bearing an effector CTL (CTLe) phenotype, defined as CD8 ϩ CD44 hi CD62L l° ( Hou and Doherty, 1993; Mobley and Dailey, 1992) . Likewise, we have shown that exposure to TCDD suppresses the CTL response in mice infected with influenza virus, resulting in fewer CTL in the lung of TCDD-treated mice (Warren et al., 2000) . We attribute this to impaired CTL generation in the regional lymph node, as exposure to TCDD reduced the number of CD4 ϩ and CD8 ϩ T cells in the lymph node, and diminished IL-2 and IFN␥ production and cytolytic activity in restimulated lymph node cells (Warren et al., 2000) .
Although the CTL response is clearly impaired in TCDDtreated mice, the basis for this suppression is unclear. Specific unanswered questions include: Why do CD8 ϩ T cells in TCDD-treated mice fail to respond adequately to antigen? How does exposure to TCDD affect the fate of stimulated antigenspecific CD8 ϩ T cells in vivo? Answering these questions has been hindered by several factors. First of all, the finding that T cell functions are not altered by in vitro exposure to TCDD precludes the use of T cell clones or other simple in vitro approaches for studying TCDD immunotoxicity (De Krey and Kerkvliet 1995; Lang et al., 1994; Lawrence et al., 1996; Lundberg et al., 1992) . Second, whereas the function of antigen-stimulated T cells is clearly suppressed by in vivo exposure to TCDD, there have been no documented effects of TCDD on naive T cells Lundberg et al., 1992; Prell et al., 1995; Pryputniewicz et al., 1998; Rhile et al., 1996) . Consequently, determining how exposure to TCDD impairs T cell function requires the assessment of antigenspecific T cells activated in vivo. However, until recently, such mechanistic studies were limited by the technical difficulties inherent in identifying and monitoring the fate of activated antigen-specific T cells in vivo.
To address mechanisms by which exposure to TCDD causes T cell dysfunction, we characterized the effects of TCDD on the fate of antigen-specific CD8 ϩ T cells following infection with influenza virus. Infection with influenza virus is a suitable model for studying how exposure to TCDD impairs antigenspecific T cells for several reasons. First, anti-influenza immunity is exquisitely sensitive to TCDD. In fact, decreased host resistance to influenza virus has been observed in mice exposed to as little as 10 ng TCDD/kg, representing the most sensitive immunotoxic effect of TCDD reported to date (Burleson et al., 1996) . Second, exposure to TCDD clearly impairs T cellmediated immune responses during infection with influenza virus, as evidenced by reduced CTL in the lung and suppressed virus-specific cytolytic activity in the lymph node of TCDDtreated mice (Warren et al., 2000) . Additionally, several tools are available to identify influenza virus-specific CD8 ϩ T cells in vivo. For example, because the T cell receptor (TCR) usage of influenza virus-specific CTL has been well characterized, the majority of influenza virus-specific CD8 ϩ T cells can be identified with clonotypic antibodies specific for a predominant V␤ chain of the TCR (Deckhut et al., 1993; Palmer et al., 1989; Tomonari and Lovering 1988; Townsend et al., 1983) . Furthermore, CD8 ϩ T cells specific for the immunodominant epitope of influenza virus nucleoprotein (NP 366 -374 ) can be visualized using soluble tetrameric complexes consisting of H-2D b ϩNP 366 (D b NP 366 ). In the present study, we used clonotypic antibodies and D b NP 366 tetramers to address why antigenspecific CD8 ϩ T cells fail to generate an adequate CTL response in TCDD-exposed mice. Specifically, we determined how TCDD affects the fate of antigen-specific CD8 ϩ T cells upon antigen stimulation, using clonal expansion, apoptosis, and anergy as endpoints.
MATERIALS AND METHODS
Virus strains and infection. Influenza virus strains A/HKx31 (gift from Dr. Michael Coppola, Argonex, Charlottesville, VA) or A/Memphis/102/72 (gift from Dr. Demetrius Moskophidis, Medical College of Georgia, Augusta, GA) were used in all experiments. A/HKx31 and A/Memphis/102/72 are both H3N2 strains of influenza virus with immunodominant nucleoprotein (NP) epitopes that differ at one amino acid residue. Virus strains were propagated in 10-day-old fertilized chicken eggs as previously described (Barrett and Inglis, 1985) . A/HKx31 titer was determined based on hemagglutination assay with chicken red blood cells. A/Memphis/102/72 titer was quantified using a plaque assay with Madin-Darby canine kidney cells (Barrett and Inglis, 1985) . Mice were anesthetized with avertin (2,2,2-tribromoethanol; Aldrich, Milwaukee, WI) and inoculated intranasally with 20 l sterile PBS containing either 120 hemagglutinating units (HAU) of A/HKx31 or 10 7 plaque forming units of A/Memphis/102/72 (equivalent to 125 HAU).
Mice. C57Bl/6 (B6) and C57Bl/10 (B10) female mice (6 -8 weeks of age) were purchased from The Jackson Laboratory (Bar Harbor, ME) and maintained in microisolator units on a 12/12 h light cycle under pathogen-free conditions. Two separate strains of Ah-responsive mice were used for these studies to take advantage of two different tools for detecting influenza virusspecific CD8 ϩ T cells in vivo. In B6 mice infected with HKx31, virus-specific CD8 ϩ T cells can be detected using class I-major histocompatibility complex (MHC) tetramers (Belz et al., 2000; Flynn et al., 1998) . In B10 mice infected with Memphis102/72, virus-specific CD8 ϩ T cells can be identified using a monoclonal antibody against the V␤11 chain of the TCR (Tomonari and Lovering, 1988) .
TCDD. TCDD (Ն99% pure, Cambridge Isotope Laboratories, Inc., Woburn, MA) was dissolved in anisole and diluted in peanut oil to yield a working stock of 1 g/ml. Mice were gavaged with TCDD (10 g/kg body weight) or peanut oil vehicle one day prior to infection with influenza virus. Although clearly immunosuppressive (Kerkvliet and Burleson, 1994) , this dose of TCDD is not overtly toxic and is well below the LD 50 in C57Bl mice (Ͼ120 g/kg; Birnbaum, 1986) .
Flow cytometric analysis. Freshly isolated mediastinal lymph node (MLN) cells were stained with combinations of the following fluorochromeconjugated antibodies purchased from BD Pharmingen (San Diego, CA) or Caltag Laboratories (Burlingame, CA): FITC-labeled anti-CD44, PE-labeled anti-CD62L, Tricolor-or APC-labeled anti-CD8, and APC-labeled anti-CD4. Appropriately labeled, isotype-matched antibodies were used to determine nonspecific fluorescence. Cells from B10 mice infected with A/Memphis/ 102/72 were stained with a biotinylated or PE-labeled clonotypic antibody specific for the V␤11 chain of the TCR to detect a majority of influenza virus-specific CD8 ϩ T cells. To identify influenza virus-specific CD8 ϩ T cells in B6 mice infected with A/HKx31, cells were incubated for 1 h at room temperature with PE-labeled D b NP 366 tetrameric complexes (generously provided by Dr. Peter Doherty, University of Melbourne, Australia). In order to evaluate apoptosis, cells were stained with FITC-labeled annexin V and 7-amino-actinomycin D (7-AAD; BD Pharmingen). Apoptotic cells were identified as annexin V-positive, 7-AAD-negative (van Engeland et al., 1998) . For all experiments, data were collected from 25,000 to 50,000 cells using a FACScan or FACSort flow cytometer (Becton Dickinson, San Jose, CA) and analyzed using WinList software (Verity Software, Topsham, ME).
Ex vivo restimulation of lymphoid cells. MLN cells were harvested, processed, and counted as previously described (Warren et al., 2000) . Cells were resuspended in cRPMI (RPMI 1640 containing 10% FBS, 2 mM Lglutamine, 1 mM sodium pyruvate, 50 g/ml gentamicin, and 50 M 2-ME) and plated at 4 ϫ 10 5 cells/well in 96-well flat-bottom tissue culture plates. Exogenous murine IL-2 (R&D Systems, Minneapolis, MN) was added to wells at 12.5 U/ml. NP 366 -374 peptides from strain A/HKx31 (ASNENMETM) or strain A/Memphis/102/72 (ASNENMDTM) were added to wells at a final concentration of 1 M. Both peptides were synthesized at the Molecular Biology Core Facility at Washington State University. Plates were incubated at 37°C and 5% CO 2 for 24 to 72 h.
In some experiments, MLN cells were depleted of CD4 ϩ or CD8 ϩ T cells prior to restimulation. Briefly, anti-CD4-or anti-CD8-conjugated magnetic beads (Dynal ASA, Oslo, Norway) were added to 5-10 ϫ 10 6 MLN cells at a ratio of four beads per target cell, incubated 20 min at 4°C with continuous end-over-end mixing, and removed by magnetic separation. The remaining
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ϩ T CELLS cells were washed three times and resuspended in cRPMI. Depletion efficacy was assessed by flow cytometry and was found to be Ն 82%. For preparation of antigen presenting cells, DC2.4 cells (provided by Dr. Ken Rock, Dana Farber Cancer Institute, Boston, MA) were resuspended at 2 ϫ 10 6 cells/ml in RPMI 1640, containing 10 mM HEPES and 1% BSA (Sigma Chemical Co., St. Louis, MO) and incubated with influenza A virus at 300 HAU/ml for 3 h at 37°C. Infected DC2.4 cells were subsequently irradiated at 3000 rad, washed twice and resuspended in cRPMI. For restimulation, 2 ϫ 10 6 MLN cells were cultured with 1 ϫ 10 6 DC2.4 cells in 24-well, flat-bottom plates and incubated at 37°C. After 24 h, supernatants were analyzed for IFN␥ by ELISA. Wells containing MLN cells from naive mice and wells with only DC2.4 cells were included as negative controls.
Measurement of IFN␥ production. Supernatants from ex vivo restimulated MLN cells were collected after 24 h. IFN␥ levels were measured using a sandwich enzyme-linked immunosorbant assay (ELISA) with reagents purchased from BD Pharmingen. The ELISA was performed according to the manufacturer's protocol. Briefly, 96-well plates (Nunc Maxisorp Immunoplates) were coated with 2g/ml rat anti-mouse IFN␥ antibody (R4-6A2) diluted in 0.1 M NaHCO 3 (pH 8.3). Samples or serially diluted recombinant murine IFN␥ standards were added to the plate in duplicate. IFN␥ was detected using 1 g/ml biotinylated rat anti-mouse IFN␥ antibody (XMG.1) followed by HRP-conjugated streptavidin. Plates were developed using 2,2Ј-azinobis(3-ethylebenzthiazoline)-6-sulfonic acid (ABTS). The lower limit of detection for this assay is 125 pg/ml.
Analysis of proliferation.
To measure T cell proliferation in vivo, 5-bromo-2Ј-deoxyuridine (BrdU; Sigma Chemical Co.) was added at 0.8 mg/ml to the drinking water three days before sacrificing mice (Flynn et al., 1999; Wynford-Thomas and Williams, 1986) . Water bottles that contained BrdU were protected from light and changed daily. Freshly isolated MLN cells were stained with anti-CD8 and either anti-V␤11 or D b NP 366 tetramers. To measure BrdU incorporation, cells were fixed, permeabilized (Tough and Sprent, 1994) , and stained with 20 l of FITC-labeled anti-BrdU or a matched isotypic control antibody (BD Pharmingen). To measure in vitro proliferation, ex vivo restimulated lymph node cells were cultured for a total of 72 h; cells were pulsed with 3 H-thymidine (2 Ci/well; Amersham Pharmacia Biotech, Piscataway, NJ) for the last 24 h. Contents of wells were harvested onto glass fiber filter strips using a cell harvester (PHD model, Cambridge Technology, Watertown, MA), and 3 H-thymidine incorporation was measured using a liquid scintillation counter.
Statistical analyses. Statistical analyses were performed using Statview (version 4.01, Abacus Concepts, Berkeley, CA). Data were evaluated by ANOVA, followed by a Fisher's least significant difference multigroup comparison. Data were considered significantly different at p Յ 0.05.
RESULTS

In Vivo Exposure to TCDD Suppresses the Expansion of Influenza Virus-Specific CD8 ϩ T Cells
The generation of CTL during infection with influenza virus is accompanied by an increase in the number of influenza virus-specific CD8 ϩ T cells in the regional lymph node (Allan et al., 1990) . To investigate how exposure to TCDD suppresses the development of an effective CTL response, clonotypic antibodies (anti-V␤11) were used to identify a population of influenza virus-specific CD8 ϩ T cells in B10 mice and characterize the effects of TCDD on the expansion of these cells. As shown in Figure 1A , infection induced a three-to fivefold increase in the number of V␤11 ϩ CD8 ϩ T cells in the MLN of vehicle-treated mice, with maximum cell number observed on day 7. In contrast, the expansion of V␤11 ϩ CD8 ϩ T cells during infection with influenza virus was reduced 40 -50% in mice exposed to TCDD. Suppressed cell recovery in TCDD-exposed mice was not observed before day 5, as the numbers of V␤11 ϩ CD8 ϩ T cells in vehicle-and TCDD-treated mice were similar on day 3. Expansion of antigen-specific cells was also suppressed in TCDD-treated mice when D b NP 366 tetramers were used to identify influenza virus-specific CD8 ϩ T cells in B6 mice infected with A/HKx31 (Fig. 1B) . Exposure to TCDD did not alter the percentage or number of V␤11 ϩ CD8 ϩ or D b NP 366 ϩCD8 ϩ T cells in uninfected mice (data not shown).
Differentiation of Naive Influenza Virus-Specific CD8 ϩ T Cells into Functional Effector Cells Is Reduced in TCDD-Treated Mice
Reduced expansion of influenza virus-specific CD8 ϩ T cells in the lymph nodes of TCDD-treated mice suggested that CTLe in the lymph nodes of B10 mice infected with influenza virus. Suppression began on day 7 post infection and peaked on day 9, which is consistent with the time at which influenza virus-specific CTLe are typically detected in the lung (Flynn et al., 1998) . Similarly, when tetramers were used to identify influenza virus-specific CTLe on day 9 post infection, exposure to TCDD reduced the number of D b NP 366 ϩ CTLe by 80% (Table 1).
Another characteristic of influenza virus-specific CTL is the production of IFN␥ (Belz et al., 2000; Flynn et al., 1998; Price et al., 2000; Taylor et al., 1989) . We have previously shown that IFN␥ levels are diminished 60% in restimulated bulk MLN cultures from TCDD-treated mice (Warren et al., 2000) . To determine the cellular source of IFN␥ in the MLN cultures, and to quantify the effects of TCDD on IFN␥ produced by CD8 ϩ T cells in particular, magnetic beads were used to deplete CD8 ϩ or CD4 ϩ T cells prior to restimulation. As shown in Figure 2 , removal of CD4 ϩ T cells did not alter IFN␥ levels in restimulated MLN cells from vehicle-or TCDD-treated mice on day 9 post infection. However, depletion of CD8 ϩ T cells ablated IFN␥ production in restimulated cells from either treatment group, indicating that CD8 ϩ T cells were the primary source of IFN␥ in the MLN cultures. Similar results were obtained on days 5 and 8 post infection (data not shown). It is important to note that diminished levels of IFN␥ in intact or CD4-depleted cultures from TCDD-exposed mice were not simply due to fewer CD8 ϩ T cells in the wells containing cells from TCDD-treated mice. The percentage and number of CD4 ϩ and CD8 ϩ T cells in these cultures were equivalent among treatment groups (data not shown), therefore, decreased levels of IFN␥ are not simply due to putting fewer T cells into the well. Taken together, these functional and phenotypic analyses demonstrate that the development of influenza virusspecific CTL is suppressed in mice exposed to TCDD. Thus, additional studies were conducted to address possible mechanisms by which virus-specific CD8 ϩ T cells failed to develop into functional CTL in TCDD-exposed mice. Note. C57Bl/10 (B10) and C57Bl/6 (B6) mice were treated with vehicle or TCDD (10 g/kg) one day prior to infection with influenza virus. (B10 mice were infected with A/Memphis/102/72, whereas B6 mice were infected with A/HKx31.) Mice were sacrificed 5 to 12 days after infection, and mediastinal lymph node cells were collected, counted, and stained for flow cytometric analysis. Data represent the average percent and number of V␤11 ϩ CD8 ϩ T cells (B10 mice) or D b NP 366 ϩ CD8 ϩ T cells (B6 mice) bearing CTLe phenotype (CD44 hi CD62L l°) . Numbers in parentheses represent SEM. For each day, six mice were used per treatment group. Asterisk indicates a significant difference when compared to vehicle-treated controls (p Յ 0.05).
FIG. 2. Treatment with TCDD reduces IFN␥ production by CD8
ϩ T cells. B6 mice were treated with vehicle or TCDD one day prior to infection with influenza virus strain A/HKx31. On day 9, MLN cells were isolated and depleted of T cell subsets using anti-CD4 or anti-CD8-conjugated magnetic beads, as described in the Materials and Methods. Remaining MLN cells were plated at 2 ϫ 10 6 cells/well and restimulated with 1 ϫ 10 6 influenza virusinfected, irradiated DC2.4 cells, which served as antigen presenting cells. Supernatants were collected after 24 h and IFN␥ levels were measured by ELISA. Data represent mean (Ϯ SEM) from three samples per treatment group. Results are representative of two separate experiments in which mice were sacrificed on days 5, 8, and 9 post infection. Asterisk indicates a significant difference when compared to vehicle group under same depletion conditions (p Յ 0.05).
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Treatment with TCDD Does Not Increase Apoptosis in Antigen-Specific CD8 ϩ T Cells
The clonal expansion and differentiation of activated CD8 ϩ T cells is counterbalanced by mechanisms to prevent or terminate T cell responses (reviewed in Van Parijs and Abbas, 1998) . One mechanism involved in T cell homeostasis is the deletion of activated T cells via apoptosis (Jones et al., 1990; Kyburz et al., 1993; Webb et al., 1990) . Based on the observation that there were fewer CTLe and less IFN␥-producing CD8 ϩ T cells in TCDD-treated mice, we addressed the possibility that TCDD impaired the development of CTL by increasing apoptosis in virus-specific CD8 ϩ T cells. To test this, virus-specific CD8 ϩ T cells from the MLN were stained immediately with annexin V and 7-AAD to assess apoptosis. The percentage of virus-specific CD8 ϩ T cells expressing an apoptotic phenotype (annexin V-positive, 7-AAD-negative) was determined by flow cytometry. Figure 3A shows representative histograms for apoptosis staining on V␤11 ϩ CD8 ϩ T cells from vehicle-or TCDD-treated B10 mice on day 7 post infection with influenza virus. Exposure to TCDD did not alter the percentage of V␤11 ϩ CD8 ϩ T cells expressing an apoptotic phenotype, nor did it affect the percentage of cells bearing a late apoptotic/necrotic (7-AAD-positive) phenotype. Furthermore, no evidence of increased apoptosis was observed in influenza virus-specific CD8 ϩ T cells from TCDD-exposed mice sacrificed throughout the course of infection (Fig. 3B) . Although increases in the number of annexin V ϩ cells were observed in samples from TCDD-treated mice, these changes were not statistically significant. Furthermore, we saw no consistent change (increase or decrease) in the percentage of apoptotic influenza virus-specific CD8 ϩ T cells in repetitions of this experiment. Likewise, no alterations in the percentage of annexin V-positive, 7-AAD-negative cells were observed when D b NP 366 tetramers were used to identify virus-specific CD8 ϩ T cells on days 8 and 9 (Fig. 3B) . Together, these results suggest that enhanced apoptosis is not a likely mechanism for the diminished generation of CTL in TCDD-treated mice.
In Vivo Proliferation of Influenza Virus-Specific CD8 ϩ T Cells Is Impaired by Exposure to TCDD
Another mechanism that may account for the decreased CTL response in TCDD-exposed mice is the induction of T cell unresponsiveness, or anergy. This was initially addressed using in vivo BrdU incorporation to determine whether exposure to TCDD impaired the proliferation of influenza virus-specific CD8 ϩ T cells in the MLN. Consistent with a report by Flynn et al. (1999) , we found that infection with influenza virus induced the proliferation of V␤11 ϩ CD8 ϩ and D b NP 366 ϩ CD8 ϩ T cells in vehicle-treated mice (Fig. 4) . In contrast, the proliferation of V␤11 ϩ CD8 ϩ T cells in TCDD-treated mice infected with influenza virus was reduced by as much as 66% on day 7 (Fig.   4A ). Exposure to TCDD did not appear to suppress proliferation before day 5, as BrdU staining on day 3 was comparable in V␤11 ϩ CD8 ϩ T cells from vehicle-and TCDD-treated mice (Fig. 4A) . Reduced proliferation in TCDD-treated mice was also observed when D b NP 366 tetramers were used to identify influenza virus-specific CD8 ϩ T cells on days 5 to 9 post infection (Fig. 4B) . These data clearly demonstrate that exposure to TCDD impairs the in vivo proliferation of antigenspecific CD8 ϩ T cells.
FIG. 3. Apoptosis is not enhanced in influenza virus-specific CD8
ϩ T cells from TCDD-exposed mice. B6 and B10 mice were exposed to vehicle or TCDD one day prior to infection with influenza virus. Freshly isolated MLN cells were stained with FITC-labeled annexin V, 7-AAD, and APC-labeled anti-CD8. Additionally, PE-labeled D b NP 366 tetramers were used to identify influenza virus-specific CD8 ϩ T cells from B6 mice infected with A/HKx31, whereas PE-labeled anti-V␤11 was used to detect influenza virus-specific 
Optimal in Vitro Restimulation Fails to Elicit Maximal Responsiveness in Influenza Virus-Specific CD8 ϩ T Cells from TCDD-Treated Mice
The observation that TCDD suppressed the in vivo proliferation of influenza virus-specific CD8 ϩ T cells suggested that these cells may have become anergic, which would prevent them from responding adequately to viral challenge. To address this possibility, we tested the ability of virus-specific CD8 ϩ T cells from infected, TCDD-exposed mice to proliferate and produce IFN␥ when restimulated ex vivo with antigen and IL-2. These culture conditions have been shown to be sufficient for stimulating the proliferation and development of effector functions in primed CD8 ϩ T cells (Curtsinger et al., 1998; Gschoesser et al., 2002; Murali-Krishna et al., 1998) . As expected, restimulation with NP 366 peptide and exogenous IL-2 induced maximal IFN␥ production in MLN cells from vehicletreated mice, compared to the addition of either NP 366 peptide or IL-2 alone (Fig. 5) . In contrast to restimulated cells from vehicle-treated mice, stimulation with NP 366 peptide and IL-2 failed to elicit IFN␥ production by MLN cells from TCDDexposed mice. In fact, the levels of IFN␥ in cultures from TCDD-treated mice were similar to those from naïve mice. Diminished levels of IFN␥ were not simply due to fewer CD8 ϩ T cells in the cultures from TCDD-exposed mice, as the number of antigen-specific CD8 ϩ T cells added to the wells was equivalent in vehicle and TCDD cultures (data not shown).
Thus, these data demonstrate that optimal stimulation conditions fail to induce IFN␥ production by influenza virus-specific CD8 ϩ T cells from TCDD-treated mice. To further assess the functional capacity of influenza virusspecific CD8 ϩ T cells from TCDD-exposed mice, we measured the proliferation of these cells in response to NP 366 peptide and IL-2. Addition of IL-2 clearly induced the proliferation of cultured MLN cells from vehicle-treated, influenza virus-infected mice (Fig. 6) . Although providing IL-2 did induce some proliferation in cells from TCDD-exposed mice, the level was about half of that observed in cells from vehicle-treated mice.
Given that proliferation was detected in cultures that contained IL-2, both in the presence and absence of NP 366 peptide, it was possible that IL-2 could drive the proliferation not only
FIG. 4. Proliferation is reduced in influenza virus-specific CD8
ϩ T cells from mice exposed to TCDD. B6 and B10 mice were gavaged with vehicle or TCDD one day prior to infection with influenza virus. In vivo proliferation was assessed by adding BrdU to drinking water (0.8 mg/ml) three days prior to sacrificing mice. Mice were sacrificed on days 3 through 12, and MLN cells were isolated and stained with FITC-labeled anti-BrdU and APC-labeled anti-CD8 antibodies as described in the Materials and Methods. Additionally, PE-labeled anti-V␤11 antibody was used to detect influenza virus-specific CD8 ϩ T cells from B10 mice infected with A/Mempis/102/72, whereas PElabeled D b NP 366 tetramers were used to stain influenza virus-specific CD8 ϩ T cells from B6 mice infected with A/HKx31. Graphs represent the number of
. Error bars depict the SEM. On every day tested, each treatment group consisted of 6 -8 B10 mice or 3-7 B6 mice. Results are representative of two separate experiments for each strain of mouse. Asterisk indicates a significant difference when compared to vehicle group (p Յ 0.05).
FIG. 5. Exogenous NP peptide and IL-2 do not stimulate IFN␥ production by influenza virus-specific CD8
ϩ T cells from TCDD-treated mice. B6 and B10 mice were treated with vehicle or TCDD one day prior to intranasal infection with influenza virus strains A/HKx31 or A/Memphis/102/72. On days 3 to 9 post infection, MLN cells were isolated and restimulated in vitro with 1 M NP 366 peptide and/or 12.5 U/ml IL-2. Supernatants were collected after 24 h of culture and IFN␥ levels were measured by ELISA. Data represent mean IFN␥ concentration Ϯ SEM (pg/ml). For each treatment group, cells from 5 to 6 mice were assessed per day. Asterisk indicates a significant difference when compared to vehicle group (p Յ 0.05), and # indicates the p value was Յ 0.06.
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ϩ T CELLS of antigen-specific CD8 ϩ T cells, but also of CD4 ϩ T cells and of CD8
ϩ T cells that were not NP-specific. Thus, we accounted for the relative contribution of proliferating CD4
ϩ T cells and non-antigen-specific CD8 ϩ T cells to the overall levels of proliferation measured in the cultures. To do this, we compared the number of CD4 ϩ , CD8 ϩ , and V␤11 ϩ CD8 ϩ T cells at the beginning of the culture period to the number of cells recovered after 72 h of culture. We found that proliferation in the cultures was not due to the expansion of CD4 ϩ T cells, as the addition of NP 366 peptide and IL-2 did not support the expansion of these cells in cultures from either vehicle-or TCDDtreated mice (Fig. 7A) . In contrast, the number of CD8 ϩ T cells from vehicle-treated cultures increased as much as two-fold under the same stimulation conditions (Fig. 7B) . However, no net increase in the number of CD8 ϩ T cells was observed in cultures from TCDD-exposed mice.
We also accounted for the proliferation of NP-specific CD8 ϩ T cells in cultures stimulated with peptide and IL-2. The number of V␤11 ϩ CD8 ϩ T cells recovered from cultures from vehicle-treated mice was two-to three-times higher than from TCDD-treated mice (Fig. 7C) . Given that the percentage of V␤11 ϩ CD8 ϩ T cells in the MLN is equivalent among vehicleand TCDD-treated mice (data not shown), suppressed expansion of these cells in cultures from TCDD-exposed mice cannot simply be due to the addition of fewer NP-specific CD8 ϩ T cells to the wells. Thus, these data clearly show that restimulation only partially restored the expansion of influenza virusspecific CD8 ϩ T cells from TCDD-exposed mice. In summary, using both IFN␥ production and proliferation as endpoints, our data indicate that exposure to TCDD induced a state of hyporesponsiveness in influenza virus-specific CD8 ϩ T cells that could not be overcome even when optimal stimulation conditions were provided.
DISCUSSION
Numerous studies have demonstrated that T cell-dependent immune responses are impaired following exposure to TCDD, yet the mechanisms by which TCDD induces T cell dysfunction are poorly understood. In the present study, we investigated how exposure to TCDD alters the fate of antigen-specific T cells activated in vivo. Specifically, we addressed mechanisms by which influenza virus-specific CD8 ϩ T cells fail to generate an adequate CTL response in TCDD-exposed mice. We used clonotypic antibodies and MHC class I-restricted tetramers to characterize the effects of TCDD on the fate of influenza virus-specific CD8 ϩ T cells upon antigen challenge. Using these tools, we found that exposure to TCDD suppressed the development of CTL in the lymph nodes of mice infected FIG. 6. Proliferation is only partially restored in restimulated MLN cultures from TCDD-exposed mice. Mice were exposed to vehicle or TCDD and infected with influenza virus as described in Figure 5 . MLN cells were restimulated in vitro for 72 h in the presence of 1 M NP 366 peptide and/or 12.5 U/ml IL-2.
3 Hthymidine was added at 2 Ci/well during the last 24 h. Data represent mean c.p.m. Ϯ SEM from triplicate wells. For each treatment group, cells from 5 to 6 mice were assessed per day. Asterisk indicates a significant difference when compared to vehicle group (p Յ 0.05).
FIG. 7.
Exogenous NP peptide and IL-2 do not support maximum proliferation of influenza virus-specific CD8 ϩ T cells from TCDD-exposed mice. B10 mice were treated with vehicle or TCDD one day prior to infection with A/Memphis/102/72. MLN cells were collected, counted and restimulated for 72 h in the presence of 1 M NP 366 peptide and 12.5 U/ml IL-2. At the end of the culture period, cells were counted and stained with antibodies specific for CD8, V␤11, and CD4. Graphs depict the mean number of CD4 ϩ (A), CD8 ϩ T cells bearing a CTLe phenotype. These findings are consistent with previously reported effects of TCDD on T cells during infection with influenza virus, including our observations that exposure to TCDD reduced the number of CTL in the lung of virusinfected mice and suppressed the ability of restimulated MLN cells to kill virus-infected target cells and produce IFN␥ (Warren et al., 2000) .
These suppressive effects of TCDD on CD8 ϩ T cells from influenza virus-infected mice are also strikingly consistent with the impaired CTL response observed in TCDD-exposed mice challenged with allogeneic P815 tumor cells. For example, exposure of mice to TCDD prior to injection with P815 cells impaired the expansion of CD8 ϩ T cells in the spleen, reduced the number of cells expressing a CTLe phenotype, and suppressed splenic CTL activity (De Krey and Kerkvliet, 1995; Kerkvliet et al., 1996) . Moreover, these suppressive effects were accompanied by reduced levels of IFN␥ and IL-2, which were produced exclusively by CD8 ϩ T cells in this model . The similarities between CTL suppression during infection with influenza virus and in the P815 tumor allograft model indicate that TCDD impairs the response of CD8
ϩ T cells to two distinct types of antigen and suggest that suppression of the CTL response in these models likely occurs via a common mechanism.
To explain why there were fewer functional antigen-specific T cells in TCDD-treated mice, we addressed the possibility that exposure to TCDD increased apoptosis in influenza virusspecific CD8 ϩ T cells. In other words, we tried to find evidence that in vivo exposure to TCDD promoted clonal deletion. However, when we examined influenza virus-specific CD8 ϩ T cells directly ex vivo, we found no evidence of enhanced apoptosis. This finding is supported by our observation in separate studies that exposure to TCDD did not alter intracellular bcl-2 levels in influenza virus-specific CD8 ϩ T cells (data not shown). The lack of direct evidence for enhanced apoptosis in our model system is consistent with that of Prell et al. (2000) , who found that exposure to TCDD did not enhance apoptosis in CD8 ϩ T cells during challenge with allogeneic P815 tumor cells. It also concurs with a recent report in which TCDD treatment did not enhance apoptosis in CD4 ϩ T cells activated with anti-CD3 (Dearstyne and Kerkvliet, 2002) . However, our findings contrast with reports by Pryputniewicz et al. (1998) and Camacho et al. (2001) , who found that exposure to TCDD increased apoptosis in activated lymphoid cells from anti-CD3-treated mice. Discrepancies between our findings and these studies may be due to differences in the amount of TCDD administered (10 g/kg versus 50 g/kg, respectively). Alternatively, it could be due to differences in methodology, as the latter studies measured apoptosis in T cells after a 24-hour in vitro culture period.
While we did not observe an effect of TCDD on apoptosis, the proliferation of influenza virus-specific CD8 ϩ T cells was clearly impaired in TCDD-exposed mice. Interestingly, suppressed proliferation of virus-specific CD8 ϩ T cells was not evident in TCDD-treated mice until day 5 post infection. This delay in suppression was observed not only in the proliferative response of virus-specific CD8 ϩ T cells, but also in the development of CTLe in the lymph node. Similar kinetics have been described for the suppressive effects of TCDD on adoptively transferred DO11.10 CD4 ϩ T cells in OVA-challenged mice (Shepherd et al., 2000) . Specifically, this study showed that the initial expansion of OVA-specific CD4 ϩ T cells was not altered in TCDD-treated recipient mice. However, in contrast to vehicle-treated mice, the initial expansion of antigen-specific cells was followed by a decrease in the number of these cells in spleens from TCDD-exposed mice. Taken together, these findings raise the possibility that exposure to TCDD does not suppress the initial activation and proliferation of antigenspecific T cells, but rather alters these cells, or the local lymph node environment, such that these functions are not sustained.
One possible explanation for the diminished function of virus-specific CD8 ϩ T cells in TCDD-exposed mice is that IL-2 levels in the lymph nodes of TCDD-treated mice are insufficient for sustaining a CD8 ϩ T cell-mediated response. Indeed, we have found that exposure to TCDD reduces IL-2 production in restimulated MLN cells, and the timing of this suppression occurs between 5 and 9 days post infection, which coincides with the impaired proliferation of influenza virusspecific CD8 ϩ T cells (Warren et al., 2000) . Furthermore, decreased IL-2 levels may contribute to the diminished CTL response in TCDD-exposed mice challenged with allogeneic tumor cells, as in vivo administration of IL-2 on days 7 to 9 was found to restore the cytolytic activity of isolated spleen cells (Prell et al., 2000) . Recent studies indicate that the role of IL-2 in maintaining the CTL response may be more complex than previously believed. For example, it has been postulated that activated CD8 ϩ T cells pass through a regulatory "checkpoint" referred to as activation-induced nonresponsiveness, which converts an initially helper-independent CTL response to a response that requires IL-2 produced by CD4 ϩ T cells (Deeths et al., 1999; Schwartz, 1990; Shrikant and Mescher, 1999; Tham and Mescher, 2001) . In light of this, it is feasible that reduced levels of IL-2 in TCDD-exposed mice may interfere with the sustained response of the virus-specific CTL, leaving the cells in a state of unresponsiveness.
The idea that exposure to TCDD induces a state of nonresponsiveness in virus-specific CD8 ϩ T cells is supported by our observation that providing antigen and exogenous IL-2 failed to induce IFN␥ production and only partially restored the proliferative response of virus-specific CD8 ϩ T cells from TCDD-exposed mice. These characteristics are consistent with recent reports describing anergy in CD8 ϩ T cells in vivo (Blish et al., 1999; Dubois et al., 1998 ; Gray et al., 1999; Preckel et al., 2001; Xiong et al., 2001) . For example, Dubois et al.
TCDD INDUCES UNRESPONSIVENESS IN CD8
ϩ T CELLS (1998) demonstrated that multiple peptide injections in vivo induced CD8 ϩ T cell tolerance characterized by decreased in vivo proliferation that was only partially restored upon in vitro restimulation. Although hyporesponsiveness in the virus-specific CD8 ϩ T cells from TCDD-treated mice could theoretically be explained by a TCDD-induced downregulation of the TCR or IL-2 receptor, we and others have found no evidence that exposure to TCDD alters the expression of these receptors (Neumann et al., 1993 , and our unpublished observations). Interestingly, neither proliferation nor IFN␥ production was suppressed when MLN cells from TCDD-exposed mice were stimulated with anti-CD3 (data not shown), which indicates that these cells are capable of responding to polyclonal stimulation. Moreover, it suggests that exposure to TCDD may impair the ability of influenza virus-specific CD8 ϩ T cells to receive or respond to signals delivered through the TCR or through the IL-2R.
Consistent with the notion that treatment with TCDD induces a state of nonresponsiveness in antigen-specific CD8 ϩ T cells, exposure to TCDD has been shown to alter the activity of APC. Thus, it is possible that the suppressive effects of TCDD on virus-specific CD8
ϩ T cells are due to the impaired ability of APC to stimulate T cells in the lymph node. In support of this, Prell and Kerkvliet (1997) reported that injection of B7-transfected allogeneic P815 tumor cells restored the CTL response in TCDD-exposed mice, indicating that impaired costimulation may be one mechanism by which exposure to TCDD suppresses the CTL response. However, on a per cell basis, exposure to TCDD has been shown to increase, not decrease, the expression of costimulatory molecules such as B7-2 on splenic dendritic cells (DC), and was found to enhance the ability of DC to stimulate allogeneic T cells ). An explanation for this paradoxical effect of TCDD on DC is that exposure to TCDD promotes activationinduced cell death in DC. Two recent studies have provided experimental evidence in support of this hypothesis. First, a report by demonstrated that exposure to TCDD decreased the total number of DC recovered from the spleen. Second, Ruby et al. (2002) recently found that exposure of a dendritic cell line to TCDD suppressed the function of NF-kB/Rel, a transcription factor important for DC maturation and survival (Rescigno et al., 1998) . In light of these findings, it is possible that treatment with TCDD impairs the survival and/or alters the function of DC presenting viral antigen in the lymph node. Such circumstances could reduce the number of influenza virus-specific CD8 ϩ T cells that are stimulated. Alternatively, exposure to TCDD could cause DC in the lymph node to deliver either partial or improper signals, thereby inducing anergy in the responding CD8 ϩ T cells. In summary, the present findings provide new information regarding possible mechanisms by which exposure to TCDD impairs T cell-mediated immune responses. By identifying and monitoring influenza virus-specific CD8 ϩ T cells with clonotypic antibodies and tetramers, we examined how exposure to TCDD alters the fate of antigen-specific CD8 ϩ T cells responding to in vivo challenge. Our data indicate that the impaired CTL response in TCDD-exposed mice is due to the induction of hyporesponsiveness in influenza virus-specific CD8 ϩ T cells. Collectively, these results strengthen the hypothesis that exposure to TCDD impedes the proper and sufficient activation of antigen-specific T cells, thereby hindering the clonal expansion and differentiation of CD8 ϩ T cells into effector CTL. Given that the molecular events involved in T cell activation during infection with influenza virus are similar to those events elicited during infection with other pathogens, our findings expand the current understanding of how TCDD affects T cell activation in general.
